Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06367699 · ClinicalTrials.gov registry record · NA
Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care (ECA-HPV)- Clinical Trial
A NA study, sponsored by Tufts Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT06367699 is a NA study that was terminated before completion, run by Tufts Medical Center. The registered enrollment target is 29 participants.
The verdict
NCT06367699, a NA study, was terminated before completion, sponsored by Tufts Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
The objective of this study is to assess the use of and satisfaction with the ECA-HPV intervention over a 16-month period, its ability to increase HPV vaccination, and the comparative effectiveness of clinic notification and adolescent ECA components on these factors.
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL ECA-HPV App with Clinic Notification and Adolescent Functions Disabled
- BEHAVIORAL ECA-HPV App with Clinic Notification Function Enabled
- BEHAVIORAL ECA-HPV App with Adolescent Function Enabled
- BEHAVIORAL ECA-HPV App with Clinic Notification and Adolescent Functions Enabled
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2024-11-13 |
| Est. Completion | 2025-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06367699
The ClinicalTrials.gov registry entry for NCT06367699 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Usual Care is the first listed.
NCT06367699 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06367699 about?
NCT06367699 is a clinical study titled "Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care (ECA-HPV)- Clinical Trial". The objective of this study is to assess the use of and satisfaction with the ECA-HPV intervention over a 16-month period, its ability to increase HPV vaccination, and the comparative effectiveness of clinic notification and adolescent ECA components on these factors.
What is the current status of trial NCT06367699?
This trial is currently terminated. It is a NA study. The enrollment target is 29 participants. The study started on 2024-11-13. Estimated completion is 2025-04-01.
What interventions are being tested in trial NCT06367699?
The interventions under investigation include: Usual Care (BEHAVIORAL), ECA-HPV App with Clinic Notification and Adolescent Functions Disabled (BEHAVIORAL), ECA-HPV App with Clinic Notification Function Enabled (BEHAVIORAL), ECA-HPV App with Adolescent Function Enabled (BEHAVIORAL), ECA-HPV App with Clinic Notification and Adolescent Functions Enabled (BEHAVIORAL).
Who is sponsoring clinical trial NCT06367699?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.